Acquisition of Mutated BRAF Is as a Major Effector of Melanoma Recurrence Which Can Be Targeted By Immuno- or Chemo-Therapy

Zaidi, S, Blanchard, M, Shim, K, Ilett, E, Kottke, T, Thompson, J, Celis, E, Pandha, H, Selby, P, Melcher, A et al, Harrington, K and Vile, R (2014) Acquisition of Mutated BRAF Is as a Major Effector of Melanoma Recurrence Which Can Be Targeted By Immuno- or Chemo-Therapy In: 17th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2014-05-21 - 2014-05-24, Washington, DC.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (UNSPECIFIED)
Divisions :	Surrey research (other units)
Authors :	Name Email ORCID Zaidi, S Blanchard, M Shim, K Ilett, E Kottke, T Thompson, J Celis, E Pandha, H h.pandha@surrey.ac.uk Selby, P Melcher, A Harrington, K Vile, R
Date :	1 May 2014
Contributors :	Contribution Name Email ORCID publisher NATURE PUBLISHING GROUP,
Uncontrolled Keywords :	Science & Technology, Life Sciences & Biomedicine, Biotechnology & Applied Microbiology, Genetics & Heredity, Medicine, Research & Experimental, Research & Experimental Medicine
Related URLs :	Author
Depositing User :	Symplectic Elements
Date Deposited :	17 May 2017 10:15
Last Modified :	23 Jan 2020 16:00
URI:	http://epubs.surrey.ac.uk/id/eprint/827077

Actions (login required)

View Item

Downloads